The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
Open accessAbstract
The fibroblast growth factor (FGF) 19 subfamily of ligands, FGF19, FGF21, and FGF23, function as hormones that regulate bile acid, fatty acid, glucose, and phosphate metabolism in target organs through activating FGF receptors (FGFR1-4). We demonstrated that Klotho and betaKlotho, homologous single-pass transmembrane proteins that bind to FGFRs, are required for metabolic activity of FGF23 and FGF21, respectively. Here we show that, like FGF21, FGF19 also requires betaKlotho. Both FGF19 and FGF21 can signal through FGFR1-3 bound by betaKlotho and increase glucose uptake in adipocytes expressing FGFR1. Additionally, both FGF19 and FGF21 bind to the betaKlotho-FGFR4 complex; however, only FGF19 signals efficiently through FGFR4. Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis. We conclude that the expression of betaKlotho, in combination with particular FGFR isoforms, determines the tissue-specific metabolic activities of FGF19 and FGF21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of KLB abolishes all effects of FGF21 in vitro and in vivo46,53–56.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 binding promotes the formation of a dimeric FGFR1c–KLB signalling complex, which activates the intracellular tyrosine kinase domains of FGFR1c and propagates signalling through phosphorylation by the kinase ERK46,53,58,59”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 elicits its biological effects by binding and activating a receptor complex composed of the co-receptor KLB and a traditional FGF receptor, fibroblast growth factor receptor 1c (FGFR1c)46,47.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“Interestingly, both FGF21 and another endocrine FGF, FGF15/19, share a requirement for KLB for signaling46,54, but what cross-talk, if any, exists between these signalling pathways in both physiological and pharmacological settings is unclear.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 signals to a receptor complex comprised of FGF receptor 1c (FGFR1c) and its co-receptor β-klotho (KLB) [[143], [144], [145], [146]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [143]
In the citing paper
“Importantly, since FGF receptors are ubiquitously expressed, endocrine FGFs require a coreceptor to provide signaling specificity, which for FGF21 and FGF19 is the coreceptor β-klotho (71, 99, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
In the citing paper
“FGF21 functions in target tissues that express the traditional FGF receptor FGFR1c and the obligate coreceptor β-klotho (2, 27, 71, 99, 124, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationReceptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467
Cited by
Sorted by citations
Items 201–300 of 748
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
So, W. Y., & Leung, P. S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21390 · Cited by 85
Murata, Y., Konishi, M., & Itoh, N. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/981315 · Cited by 87
Dostálová, I., Haluzíková, D., & Haluzı́k, M. (2009) · Physiological Research · doi:10.33549/physiolres.931610 · Cited by 83
FGF 21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation
Yan, X., Chen, J., Zhang, C., Zhou, S., Zhang, Z., Chen, J., Feng, W., Li, X., & Tan, Y. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12530 · Cited by 85
Wang, H., Xiao, Y., Fu, L., Zhao, H., Zhang, Y., Wan, X., Qin, Y., Huang, Y., Gao, H., & Li, X. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-14 · Cited by 84
Klotho Coreceptors Inhibit Signaling by Paracrine Fibroblast Growth Factor 8 Subfamily Ligands
Goetz, R. M., Ohnishi, M., Ding, X., Kurosu, H., Wang, L., Akiyoshi, J., Ma, J., Gai, W., Sidis, Y., Pitteloud, N., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06603-11 · Cited by 86
Self-citationFGF19 and FGF21: In NASH we trust
Talukdar, S., & Kharitonenkov, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101152 · Cited by 82
Kuro‐o, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_2 · Cited by 80
Self-citationOut, C., Groen, A. K., & Brufau, G. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834f0ef3 · Cited by 85
Kuro-o, M. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy126 · Cited by 80
Self-citationSchumacher, J. D., Kong, B., Wu, B. J., Rizzolo, D., Armstrong, L. E., Chow, M. D., Goedken, M. J., Lee, Y., & Guo, G. L. (2019) · Hepatology · doi:10.1002/hep.30810 · Cited by 81
Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression
Feng, S., Dakhova, O., Creighton, C., & Ittmann, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4108 · Cited by 79
Francisco Barrera, M., Azócar, L., Molina, H., Schalper, K. A., Ocares, M., Liberona, J., Villarroel, L. A., Pimentel, F., Pérez‐Ayuso, R. M., Nervi, F. O., et al. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30766-5 · Cited by 78
β-Klotho gene variation is associated with liver damage in children with NAFLD
Dongiovanni, P., Crudele, A., Panera, N., Romito, I., Meroni, M., Stefanis, C. D., Palma, A., Comparcola, D., Fracanzani, A. L., Miele, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.011 · Cited by 78
Lin, B. C., & Desnoyers, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_12 · Cited by 78
Araki, M., Nakagawa, Y., Oishi, A., Han, S., Wang, Y., Kumagai, K., Ohno, H., Mizunoe, Y., IWASAKI, H. O., Sekiya, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072148 · Cited by 82
Jackson, T. C., & Kochanek, P. M. (2019) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2019.0001 · Cited by 77
Poh, W., Wong, W., Ong, H., Aung, M. O., Lim, S. G., Chua, B. T., & Ho, H. K. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-14 · Cited by 76
Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins
Latko, M., Czyrek, A. A., Porębska, N., Kucińska, M. K., Otlewski, J., Zakrzewska, M., & Opaliński, Ł. (2019) · Cells · doi:10.3390/cells8050455 · Cited by 76
FGF21 reverses MASH through coordinated actions on the CNS and liver
Rose, J. P., Morgan, D. A., Sullivan, A. I., Fu, X., Inigo-Vollmer, M., Burgess, S. C., Meyerholz, D. K., Rahmouni, K., & Potthoff, M. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.014 · Cited by 75
Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones
Adams, A. C., Coşkun, T., Cheng, C., O’Farrell, L. S., DuBois, S. L., & Kharitonenkov, A. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.05.005 · Cited by 75
Plasma FGF21 displays a circadian rhythm during a 72‐h fast in healthy female volunteers
Andersen, B., Beck‐Nielsen, H., & Højlund, K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04084.x · Cited by 74
Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)
Farrow, E., Imel, E. A., & White, K. E. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.020 · Cited by 75
Audette, D. S., Anand, D., So, T., Rubenstein, T., Lachke, S. A., Lovicu, F. J., & Duncan, M. K. (2015) · Development · doi:10.1242/dev.127860 · Cited by 74
Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
Zhang, J., & Li, Y. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.021 · Cited by 73
The potential function and clinical application of FGF21 in metabolic diseases
Chen, Z., Yang, L., Liu, Y., Huang, P., Song, H., & Zheng, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1089214 · Cited by 73
Rader, D. J., Maratos-Flier, E., Nguyen, A., Hom, D., Ferriere, M., Li, Y., Kompa, J., Martic, M., Hinder, M., Basson, C. T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab624 · Cited by 72
Samms, R. J., Cheng, C. C., Kharitonenkov, A., Gimeno, R. E., & Adams, A. C. (2016) · Endocrinology · doi:10.1210/en.2015-1722 · Cited by 76
Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects
Lei, Y., Wang, L., Guo, K., Hou, Y., Li, N., Wang, S., Liu, X., Zhao, Q., Zhou, J., Zhao, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27584-y · Cited by 74
Self-citationJin, L., Yang, R., Geng, L., & Xu, A. (2023) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032322-093904 · Cited by 71
Dual actions of fibroblast growth factor 19 on lipid metabolism
Wu, X., Ge, H., Baribault, H., Gupte, J., Weiszmann, J., Lemon, B. D., Gardner, J., Fordstrom, P., Tang, J., Zhou, M., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027094 · Cited by 71
Babaknejad, N., Nayeri, H., Hemmati, R., Bahrami, S., & Esmaillzadeh, A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0623-2909 · Cited by 70
Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
Zhang, J., & Li, Y. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00168 · Cited by 70
Goto, T., Hirata, M., Aoki, Y., Iwase, M., Takahashi, H., Kim, M., Li, Y., Jheng, H., Nomura, W., Takahashi, N., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767590 · Cited by 72
Ciaula, A. D., Bonfrate, L., Baj, J., Khalil, M., Garruti, G., Stellaard, F., Wang, H. H., Wang, D. Q. ‐., & Portincasa, P. (2022) · Nutrients · doi:10.3390/nu14234950 · Cited by 76
Nygaard, E., Møller, C. L., Kievit, P., Grove, K. L., & Andersen, B. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.79 · Cited by 69
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
Li, H., Zhang, J., & Jia, W. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0244-8 · Cited by 67
Kruse, R., Vienberg, S. G., Vind, B. F., Andersen, B., & Højlund, K. (2017) · Diabetologia · doi:10.1007/s00125-017-4373-5 · Cited by 69
Fibroblast growth factor-21 controls dietary protein intake in male mice
Larson, K. R., Chaffin, A. T.-B., Goodson, M. L., Fang, Y., & Ryan, K. K. (2019) · Endocrinology · doi:10.1210/en.2018-01056 · Cited by 68
Cantley, J. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9538-7 · Cited by 72
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Markan, K. R., Naber, M. C., Small, S. M., Peltekian, L., Kessler, R. L., & Potthoff, M. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.03.009 · Cited by 70
Jones, S. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_11 · Cited by 70
Factors mediating exercise‐induced organ crosstalk
Sabaratnam, R., Wojtaszewski, J. F. P., & Højlund, K. (2022) · Acta Physiologica · doi:10.1111/apha.13766 · Cited by 70
The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Ramos, D. C., Almeda‐Valdés, P., Aguilar-Salinas, C. A., Cuevas-Ramos, G., Cuevas-Sosa, A., & Gomez-Perez, F. J. (2009) · Current Diabetes Reviews · doi:10.2174/157339909789804396 · Cited by 70
Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
Cheng, P., Zhang, F., Yu, L., Lin, X., He, L., Li, X., Lu, X., Yan, X., Tan, Y., & Zhang, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1540267 · Cited by 66
The FGF21 Receptor Signaling Complex
Kilkenny, D. M., & Rocheleau, J. V. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.008 · Cited by 68
Sex differences in the hormonal and metabolic response to dietary protein dilution
Larson, K. R., Russo, K. A., Fang, Y., Mohajerani, N., Goodson, M. L., & Ryan, K. K. (2017) · Endocrinology · doi:10.1210/en.2017-00331 · Cited by 66
Phan, P., Saikia, B. B., Sonnaila, S., Agrawal, S., Alraawi, Z., Kumar, T. K. S., & Iyer, S. (2021) · Cells · doi:10.3390/cells10092418 · Cited by 70
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
Kohara, M., Masuda, T., Shiizaki, K., Akimoto, T., Watanabe, Y., Honma, S., Sekiguchi, C., Miyazawa, Y., Kusano, E., Kanda, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178971 · Cited by 66
Self-citationHo, H. K., Yeo, A. H. L., Kang, T. S., & Chua, B. T. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.021 · Cited by 65
Hultman, K., Scarlett, J. M., Baquero, A. F., Cornea, A. M., Zhang, Y., Salinas, C. B. G., Brown, J. M., Morton, G. J., Whalen, E. J., Grove, K. L., et al. (2019) · The Journal of Comparative Neurology · doi:10.1002/cne.24668 · Cited by 65
The Klotho gene family and the endocrine fibroblast growth factors
Kurosu, H., & Kuro‐o, M. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282ffd994 · Cited by 65
Self-citationSchumacher, J. D., & Guo, G. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_228 · Cited by 64
Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
Aaldijk, A. S., Verzijl, C. R. C., Jonker, J. W., & Struik, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1150222 · Cited by 63
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
Vacca, M., Degirolamo, C., Mariani‐Costantini, R., Palasciano, G., & Moschetta, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.137 · Cited by 66
Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues
Lin, X., Liu, Y. B., & Hu, H. (2017) · Biomedical Reports · doi:10.3892/br.2017.890 · Cited by 61
Nrf2 induces fibroblast growth factor 21 in diabetic mice
Furusawa, Y., Uruno, A., Yagishita, Y., Higashi, C., & Yamamoto, M. P. (2014) · Genes to Cells · doi:10.1111/gtc.12186 · Cited by 62
Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
Jahn, D., Rau, M., Hermanns, H. M., & Geier, A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.016 · Cited by 65
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
Li, X., Stanislaus, S., Asuncion, F., Niu, Q.-T., Chinookoswong, N., Villasenor, K., Wang, J., Wong, P., Boyce, R., Dwyer, D., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2936 · Cited by 61
Khazaeli, P., Alaei, M., Khaksari, M., & Ranjbar, M. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00737-9 · Cited by 61
Yano, K., Yamaguchi, K., Seko, Y., Okishio, S., Ishiba, H., Tochiki, N., Takahashi, A., Kataoka, S., Okuda, K., Liu, Y. X., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00680-9 · Cited by 63
Polyethylene Glycol Modified FGF21 Engineered to Maximize Potency and Minimize Vacuole Formation
Xu, J., Bussiere, J. L., Yie, J., Sickmier, E. A., An, P., Belouski, E., Stanislaus, S., & Walker, K. W. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300603k · Cited by 61
Laeger, T., Baumeier, C., Wilhelmi, I., Würfel, J., Kamitz, A., & Schürmann, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4389-x · Cited by 59
Struik, D., Dommerholt, M. B., & Jonker, J. W. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000599 · Cited by 61
Scalzo, R. L., Peltonen, G. L., Giordano, G., Binns, S. E., Klochak, A. L., Paris, H. L. R., Schweder, M. M., Szallar, S. E., Wood, L. M., Larson, D. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090696 · Cited by 60
Fibroblast growth factor‐21 protects against fibrosis in hypertensive heart disease
Ferrer‐Curriu, G., Redondo‐Angulo, I., Guitart‐Mampel, M., Rupérez, C., Mas‐Stachurska, A., Sitges, M., Garrabou, G., Villarroya, F., Fernández‐Solà, J., & Planavila, A. (2018) · The Journal of Pathology · doi:10.1002/path.5226 · Cited by 60
FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/β-Klotho Bispecific Protein
Smith, R. J., Duguay, A. N., Bakker, A., Li, P., Weiszmann, J., Thomas, M. R., Alba, B. M., Wu, X., Gupte, J., Li, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061432 · Cited by 59
Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases
Li, X., Lu, W., Kharitonenkov, A., & Luo, Y. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13767 · Cited by 64
Gilroy, C. A., Roberts, S., & Chilkoti, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.015 · Cited by 58
Amino acid transporters in the regulation of insulin secretion and signalling
Javed, K., & Fairweather, S. J. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180250 · Cited by 64
Chen, M. Z., Chang, J. C., Zavala-Solorio, J., Kates, L., Thai, M., Ogasawara, A., Bai, X., Flanagan, S., Nunez, V., Phamluong, K., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.09.003 · Cited by 58
Wanders, R. J. A. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-6889-5_2 · Cited by 58
Hepatic Crtc2 controls whole body energy metabolism via a miR-34a-Fgf21 axis
Han, H.-S., Choi, B. H., Kim, J. S., Kang, G. W., & Koo, S. (2017) · Nature Communications · doi:10.1038/s41467-017-01878-6 · Cited by 58
Zhang, S., Li, R. J. W., Lim, Y.-M., Batchuluun, B., Liu, H., Waise, T. M. Z., & Lam, T. K. T. (2020) · Gut · doi:10.1136/gutjnl-2020-321757 · Cited by 58
Muise, E. S., Souza, S., Chi, A., Tan, Y., Zhao, X., Liu, F., Dallas-yang, Q., Wu, M., Sarr, T., Zhu, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073011 · Cited by 57
Significance of the anti-aging protein Klotho
Dërmaku‐Sopjani, M., Kolgeci, S., Abazi, S., & Sopjani, M. (2013) · Molecular Membrane Biology · doi:10.3109/09687688.2013.837518 · Cited by 59
Somm, E., Henry, H., Bruce, S. J., Aeby, S., Rosikiewicz, M., Sykiotis, G. P., Asrih, M., Jornayvaz, F. R., Denechaud, P., Albrecht, U., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91809 · Cited by 58
Self-citationMaekawa, R., Seino, Y., Ogata, H., Murase, M., Iida, A., Hosokawa, K., Joo, E., Harada, N., Tsunekawa, S., Hamada, Y., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.010 · Cited by 56
Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
Villarroya, J., Gallego-Escuredo, J. M., Delgado‐Anglés, A., Cairó, M., Moure, R., Mateo, M. G., Domingo, J. C., Domingo, P., Giralt, M., & Villarroya, F. (2018) · Aging Cell · doi:10.1111/acel.12822 · Cited by 56
Ge, H., Zhang, J., Gong, Y., Gupte, J., Ye, J., Weiszmann, J., Samayoa, K., Coberly, S. K., Gardner, J., Wang, H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592022 · Cited by 56
Lee, K. J., Jang, Y. O., Cha, S., Kim, M. Y., Park, K., Eom, Y. W., & Baik, S. K. (2018) · Gut and Liver · doi:10.5009/gnl17443 · Cited by 56
Hormone-like fibroblast growth factors and metabolic regulation
Long, Y. C., & Kharitonenkov, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.002 · Cited by 55
Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage
Luo, Y., Ye, S., Chen, X., Gong, F., Lu, W., & Li, X. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.08.001 · Cited by 56
Triantis, V., Saeland, E., Bijl, N., Elferink, R. P. J. O., & Jansen, P. L. M. (2010) · Hepatology · doi:10.1002/hep.23708 · Cited by 55
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54
Zhang, J., Gupte, J., Gong, Y., Weiszmann, J., Zhang, Y., Lee, K. J., Richards, W. G., & Li, Y. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.016 · Cited by 54
The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects
Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, . M., & Batiha, G. E. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01240-x · Cited by 54
Luo, Y., Yang, C., Lu, W., Xie, R., Jin, C., Huang, P., Wang, F., & McKeehan, W. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148288 · Cited by 54
Li, K., Li, L., Yang, M., Liu, H., Boden, G. H., & Yang, G. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.026 · Cited by 55
Schumacher, J. D., Kong, B., Pan, Y., Zhan, L., Sun, R., Aa, J., Rizzolo, D., Richardson, J. R., Chen, A., Goedken, M., et al. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.06.023 · Cited by 53
Katafuchi, T., Esterházy, D., Lemoff, A. S., Ding, X., Sondhi, V., Kliewer, S. A., Mirzaei, H., & Mangelsdorf, D. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.004 · Cited by 53
Self-citationFletcher, J. A., Meers, G. M.-E., Laughlin, M. H., Ibdah, J. A., Thyfault, J. P., & Rector, R. S. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-091 · Cited by 53
Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis
Lee, J., Hong, S., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S. W., & Lee, W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.011 · Cited by 52
Fibroblast growth factor 15/19 expression, regulation, and function: An overview
Guthrie, G. J., Vonderohe, C. E., & Burrin, D. G. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111617 · Cited by 57
Ye, X., Guo, Y., Zhang, Q., Chen, W., Hua, X., Liu, W., Yang, Y., & Chen, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055615 · Cited by 52
Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders
Suomalainen, A. (2013) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.812070 · Cited by 52
Altered FGF signalling in congenital craniofacial and skeletal disorders
Moosa, S., & Wollnik, B. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.12.005 · Cited by 54
Jin, L., Lin, Z., & Xu, A. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.1.22 · Cited by 52
FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho
Fu, T., Kim, Y., Byun, S., Kim, D.-H., Seok, S., Suino-Powell, K. M., Xu, H. E., KEMPER, B. W., & Kemper, J. K. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1226 · Cited by 53
Huang, Z., Wang, H., Lu, M., Sun, C., Wu, X., Tan, Y., Ye, C., Zhu, G., Wang, X., Cai, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020669 · Cited by 51
Metadata
- Authors
- Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 282
- Issue
- 37
- Pages
- 26687-26695
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2496965
- OpenAlex
- W2048411348
- Cited by
- 748
- References
- 35
- Citations by year
- 2026: 37 · 2025: 24 · 2024: 33 · 2023: 31 · 2022: 55 · 2021: 46 · 2020: 44 · 2019: 48 · 2018: 52 · 2017: 47 · 2016: 38 · 2015: 40 · 2014: 43 · 2013: 43 · 2012: 51
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- Welch Foundation
- Ted Nash Long Life Foundation
- Eisai
- National Institutes of Health (1r01ag015326-01, DK067158)
- National Institute on Aging (R01AG19712, R01AG025326, R01 AG 15326, R01AG019712)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-067158, R01DK067158)
- National Institute of Dental and Craniofacial Research (R01DE13686, R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- β-Klotho, Klotho, FGF19, FGF21, fibroblast growth factor 23, fibroblast growth factor receptor, FGFR4, FGFR1, tissue-specific signaling, bile acid metabolism, CYP7A1, hepatocytes, metabolic hormones
- MeSH terms
- Fibroblast Growth Factor-23, Klotho Proteins, Animals, Cholesterol 7-alpha-Hydroxylase, Fibroblast Growth Factors, Humans, Membrane Proteins, Organ Specificity, Phosphorylation, Signal Transduction, Adipocytes, Protein Isoforms, Hepatocytes, 3T3-L1 Cells, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
